Skip to nav Skip to content

53 article(s) found

Patient Composes Songs Inspired by Glioblastoma Journey

Dan Helphrey’s music has become a source of comfort for fellow patients, caregivers and his Moffitt team

Brain scan image with a doctor's hand, representing medical diagnosis and research

Could Routine Brain Scans Change Care for Late-Stage Breast Cancer Patients?

Moffitt trial is investigating the benefits of earlier brain surveillance and metastasis intervention

Kosj Yamoah, MD, PhD, had just started working at Moffitt Cancer Center as a radiation oncologist when his son, Zion, was diagnosed with a rare and aggressive childhood brain cancer.

A Father’s Promise

In his short life, Zion Yamoah left a long legacy that continues with new proton therapy center

Turning Music Into Moments of Healing and Connection

Lloyd Goldstein named first recipient of the Patti K. Halula Legacy Award for nearly two decades of service through Moffitt’s Arts in Medicine program

Lorraine Portelance, MD, is an internationally recognized pioneer in groundbreaking radiation modalities, and she is helping to usher in a new era of cancer treatment with proton therapy at Moffitt.

The Future of Radiation Is on Her Mind, But the Patients Are in Her Heart

Radiation oncologist Lorraine Portelance, MD, sees proton therapy as an ‘ideal weapon’ for targeting cancer

Can Triplet Therapy Help Treat Symptomatic Melanoma Brain Metastases?

Targeted therapy combined with immunotherapy gave patients longer progression-free survival and higher response rates, study says

Anna Phelan lying in a hospital bed, smiling at the camera

Young TikTok Star Shares Glioblastoma Journey

Anna Grace Phelan died from the rare and aggressive brain cancer at 19

A researcher puts liquid on a petri dish.

New Hope on the Horizon for Fighting Leptomeningeal Disease

Targeting branched-chain keto acids with phenylbutyrate could lead to better outcomes for those with leptomeningeal disease

Moffitt Treats First Glioblastoma Patient in Florida Using New Technology

Carthera’s Sonocloud-9 could eliminate challenges presented by the blood-brain barrier